Dibutylone


Dibutylone is a stimulant drug of the amphetamine, phenethylamine, cathinone, and phenylisobutylamine families. It is structurally related to butylone, a designer drug that has been detected in products marketed as bath salts or plant food.
In 2018, dibutylone was the third most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.

Legal status

In United States, dibutylone is on the list of Schedule I Controlled Substances as a positional isomer of pentylone.